Johnson & Johnson / Corporate Member Profile

JOHNSON & JOHNSON DISTRIBUTION CENTER

This LEED Gold certified distribution center incorporates a traditional tilt-up design which defines the standards for all future facilities in the new industrial park.

Johnson & Johnson, a world leader in consumer health products, medical devices, pharmaceuticals and biologics teamed with The Lamar Johnson Collaborative and Clayco to design and build their new Midwest distribution center. The design of this building, which was the first in the new 70 West Commerce Center park, set the standard for all future facilities in the park. The facility was honored with LEED Gold Certification due to the collaboration of the design team and commitment Johnson & Johnson placed on sustainability and the environment.

The facility design incorporates tilt-up concrete construction, energy efficient mechanical and electrical systems, 100% emergency back-up power and vertical lift dock levelers. The 30,000-square-foot main office area is detailed with energy efficient glazing and the entry is identified with a composite metal canopy.

220px-Johnson_and_Johnson_Logo.svg.png
250px-JohnsonJohnson_HQ_building.jpg

Headquarters at One Johnson & Johnson Plaza in New Brunswick, New Jersey

Type Public
Traded as NYSEJNJ

DJIA Component

S&P 100 Component

S&P 500 Component

ISIN US4781601046
Industry Pharmaceutical

Medical devices

Consumer healthcare

Founded January 1886; 135 years ago

New Brunswick, New Jersey, United States

Founders Robert Wood Johnson I

James Wood Johnson

Edward Mead Johnson

Headquarters One Johnson & Johnson Plaza, New Brunswick, New Jersey, U.S.
Area served Worldwide
Key people Alex Gorsky (Chairman and CEO)[1]

Paul Stoffels (Vice Chairman of the Executive Committee and Chief Scientific Officer)[2]

Joaquin Duato (Vice Chairman of the Executive Committee)[3]

Products See list of Johnson & Johnson products
Revenue 11px-Increase2.svg.png.webp US$82.584 billion (2020)[4]
Operating income 11px-Decrease2.svg.png.webp US$19.733 billion (2020)[4]
Net income 11px-Decrease2.svg.png.webp US$14.714 billion (2020)[4]
Total assets 11px-Increase2.svg.png.webp US$170.693 billion (2020)[5]
Total equity 11px-Increase2.svg.png.webp US$64.473 billion (2020)[5]
Number of employees 11px-Decrease2.svg.png.webp 132,200 (2019)[6]
Subsidiaries Janssen Pharmaceutica

Janssen Biotech

Crucell

Cilag

Tibotec

Actelion

Ethicon Inc.

DePuy Synthes

Synthes

Acclarent

Mentor

Johnson & Johnson Vision

McNeil Consumer Healthcare

Website www.jnj.com